Navigation Links
Resonant Medical Appoints New Vice President of Global Sales
Date:9/10/2007

MONTREAL, Sept. 10 /PRNewswire/ - Resonant Medical, the world leader in 3D ultrasound image-guided adaptive radiotherapy products, announced today that Mr. Joe Redfearn has joined the Company as Vice President Global Sales. This is a new position for Resonant Medical, and in this role, Mr. Redfearn will be responsible for the Company's global sales and customer support activities. He will also contribute to the expansion of the international distribution network.

"Mr. Redfearn brings to Resonant a track record of successful capital equipment sales and support management," said Steve Arless, Resonant's president & CEO. "His experience in the US and international marketplaces will help us achieve our bold goals for the coming years.

Mr. Redfearn joins the Company from Stereotaxis, where he was Vice-President of Capital Sales. He is a seasoned executive that has grown in the medical device industry for over 25 years, where he has worked for CryoCath Technologies, ThermoCardio Systems and CR Bard. "I'm excited to join the Resonant Medical Team and look forward to leading Resonant's efforts toward profitable revenue growth" commented Redfearn. "With new top management and proven product performance, Resonant is well-positioned for significant sales growth."

About Resonant Medical and Restitu(TM)

Resonant Medical Inc. is the world leader in 3D ultrasound image-guided radiotherapy products designed to improve treatment planning, verification and delivery. Recently, the company secured significant financing in order to develop and market Restitu(TM) add-on modules that will improve the quality of radiotherapy treatment for patients with breast, head & neck, cervix, bladder, and other soft tissue malignancies. These modules will compliment the previously released prostate module and Restitu(TM) platform, which are already in use in dozens of cancer clinics and university hospitals in North America.

The Restitu(TM) Platform accurately visualizes and corrects daily changes in tumor position, shape and size, thus ushering in a new era of 3D ultrasound (U/S) multimodality radiotherapy treatment planning and image guidance. Installed in CT-Sim rooms, Restitu U/S-Sim(TM) allows for better definition of planning tumor volumes with its patented IMPLICIT REGISTRATION(TM) technology that automatically fuses 3D U/S to CT data. With U/S-Sim, multimodality treatment planning has now been made possible and affordable for all clinics, with or without PET or MRI. Installed in treatment rooms, Restitu U/S-Guide(TM) allows for highly accurate patient position verification and alignment, with its proprietary MUTUAL REFERENCING(TM) technology that uses assisted segmentation for efficient and robust intramodality 3D U/S image-guidance.


'/>"/>
SOURCE Resonant Medical inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Check if your “Favourite medical web-site” is indulging in Quackey
2. Teens turning to Internet for medical queries
3. Ayurvedic Therapies Cashing In On Medical Tourism
4. Robots craft medical history
5. NBE to conduct test for medical students from abroad
6. Air pollution combined with greater medical needs
7. Indian Nationals with Foreign Medical Degrees can now practice in India
8. Children! Protecting them from medical mistakes
9. More information sought by patients on medical errors
10. SARS necessitates medical masks
11. Meditation Works Medically
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping ... fitness app. The fitness app plans to fix the two major problems leading the fitness ... size fits all type program , They don’t eliminate all the reasons people ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: